SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008502
Filing Date
2022-05-09
Accepted
2022-05-09 16:15:38
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-20220331.htm   iXBRL 10-Q 2278737
2 EX-31.1 rcus-ex31_1.htm EX-31.1 18378
3 EX-31.2 rcus-ex31_2.htm EX-31.2 18426
4 EX-32.1 rcus-ex32_1.htm EX-32.1 10814
5 EX-32.2 rcus-ex32_2.htm EX-32.2 10840
  Complete submission text file 0000950170-22-008502.txt   8333751

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20220331_def.xml EX-101.DEF 215786
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20220331.xsd EX-101.SCH 74403
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rcus-20220331_cal.xml EX-101.CAL 48342
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20220331_lab.xml EX-101.LAB 478202
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20220331_pre.xml EX-101.PRE 349873
60 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20220331_htm.xml XML 1445553
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 22905138
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences